Insider · CIK 0001720602
Michael Sardano
Files at SRTS (Sensus Healthcare, Inc.). First filing Aug 14, 2025, latest Nov 19, 2025.
Michael Sardano files SEC Form 4 as president and director at SRTS (Sensus Healthcare, Inc.). Since Aug 14, 2025, Michael Sardano has reported 5 open-market buys worth $28k and 0 open-market sells worth $0, the latest filed on Nov 19, 2025.
A track record needs three past buys with six months of prices behind them; Michael Sardano has 0, so none is measured yet.
The newest scored trade: bought $3,800 of SRTS on Nov 18, 2025, filed Nov 19, 2025, scored 35 (weak). In the last 12 months: 4 buys worth $25k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SRTS: Sensus Healthcare, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Sensus Healthcare, Inc. | $3,800 1,000 shares | +1% | - | |
| 40Moderate | Sensus Healthcare, Inc. | $8,546 2,000 shares | +2% | - | |
| 40Moderate | Sensus Healthcare, Inc. | $8,523 2,000 shares | +2% | - | |
| 35Weak | Sensus Healthcare, Inc. | $4,260 1,000 shares | +1% | - | |
| 15Weak | SRTSbuy Sensus Healthcare, Inc. | $3,370 1,000 shares | +1% | - |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | SRTS Sensus Healthcare, Inc. | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 158,839 | Dec 16, 2025 |
| Nov 18, 2025 | SRTS Sensus Healthcare, Inc. | POpen-market purchase Common Stock | +1,000 | $3.80 | $3,800 | 118,839 | Nov 19, 2025 |
| Nov 11, 2025 | SRTS Sensus Healthcare, Inc. | POpen-market purchase Common Stock | +1,000 | $4.26 | $4,260 | 117,839 | Nov 18, 2025 |
| Nov 11, 2025 | SRTS Sensus Healthcare, Inc. | POpen-market purchase Common Stockindirect: spouse | +766 | $4.27 | $3,271 | 766 | Nov 18, 2025 |
| Nov 11, 2025 | SRTS Sensus Healthcare, Inc. | POpen-market purchase Common Stockindirect: spouse | +234 | $4.34 | $1,016 | 1,000 | Nov 18, 2025 |
| Nov 11, 2025 | SRTS Sensus Healthcare, Inc. | POpen-market purchase Common Stock | +1,000 | $4.26 | $4,260 | 117,839 | Nov 13, 2025 |
| Nov 11, 2025 | SRTS Sensus Healthcare, Inc. | POpen-market purchase Common Stockindirect: spouse | +766 | $4.27 | $3,271 | 118,605 | Nov 13, 2025 |
| Nov 11, 2025 | SRTS Sensus Healthcare, Inc. | POpen-market purchase Common Stockindirect: spouse | +234 | $4.24 | $992 | 118,839 | Nov 13, 2025 |
| Nov 11, 2025 | SRTS Sensus Healthcare, Inc. | POpen-market purchase Common Stock | +1,000 | $4.26 | $4,260 | 117,839 | Nov 12, 2025 |
| Aug 13, 2025 | SRTS Sensus Healthcare, Inc. | POpen-market purchase Common Stock | +1,000 | $3.37 | $3,370 | 116,839 | Aug 14, 2025 |
| Dec 17, 2024 | SRTS Sensus Healthcare, Inc. | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 114,839 | Dec 19, 2024 |
Questions about Michael Sardano
Answered from the filings on this page, as of the latest one.
Is Michael Sardano buying or selling?
In the last 12 months Michael Sardano reported 4 open-market buys worth $25k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $3,800 of SRTS on Nov 18, 2025. Grants, option exercises and tax withholding are not counted.
How did Michael Sardano's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael Sardano has 0.
Where does Michael Sardano file Form 4?
Michael Sardano has filed Form 4 at SRTS (Sensus Healthcare, Inc.) as PRESIDENT AND GENERAL COUNSEL. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.